Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Rectal Neoplasms 6Esophageal Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Head and Neck Neoplasms 5Uterine Cervical Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Pancreatic Neoplasms 3Lung Neoplasms 3Carcinoma, Squamous Cell 3Stomach Neoplasms 2Nasopharyngeal Carcinoma 2Mouth Neoplasms 2Glioblastoma 2Carcinoma 2Adenocarcinoma 2Tonsillar Neoplasms 1Thrombocytopenia 1Resectable Esophageal Cancer 1Pharyngeal Neoplasms 1Pain 1Oropharyngeal Neoplasms 1Neoplasms, Multiple Primary 1Neoplasms by Site 1Neoplasms 1Nasopharyngeal Neoplasms 1Melanoma 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Limited Stage Small Cell Lung Cancer 1Irritable Bowel Syndrome 1

Interventions

tislelizumab 1Tirapazamine 1Radiotherapy 1Radiation 1Etoposide 1Cisplatin 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Limited Stage Small Cell Lung Cancer × Chemoradiotherapy × Clear all
NCT04952597 2024-10-26

Study of Ociperlimab Plus Tislelizumab Plus Chemoradiotherapy in Participants With Untreated Limited-Stage Small Cell Lung Cancer

BeiGene

Phase 2 Completed
126 enrolled 19 charts
Thoracic

Limited Stage Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡